People living with this rare blood cancer often deal with complex and unpredictable symptoms. Connecting with support and ...

Source: Getty Images Primary myelofibrosis is a rare cancer. In the United States (US), the annual incidence is approximately 0.3 cases per 100,000 individuals. The median age of patients with ...

Panelists discuss how myelofibrosis progresses from its molecular and genetic origins through various clinical manifestations ...

Allogeneic hematopoietic stem-cell transplantation is the only curative treatment for myelofibrosis. Driver mutations are the pathophysiological hallmark of the disease, but the role of mutation ...

Opens in a new tab or window Clearance of driver mutations at day 30 after transplantation was associated with a reduced risk of relapse and better survival among patients with myelofibrosis ...

It was Jan. 18, and FIU softball coach Mike Larabee had just finished conducting practice. He gathered his team on the grass in right field and told them he was going to miss the 2025 season due to ...

A bone marrow biopsy can identify diseases of the bone marrow, including myelodysplastic syndrome or myelofibrosis, and conditions that affect the blood cells, such as leukopenia, polycythemia ...

Allogenic haematopoietic stem cell transplantation (allo-HSCT) can induce bone marrow fibrosis regression in patients with myelofibrosis (MF) however, the effect on the skeleton is unclear.

The bone marrow is the spongy part of your bones where oxygen-carrying red bloods, infection-fighting white blood cells, and clot-forming platelets are made. The bone marrow is a soft tissue with many ...